ZIMMER BIOMET HLDGS DL-01
ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
ZIM
16/08/2024 8:04:18
|
Diferencia
-0.120
|
Volumen |
Bid18:52:22 |
Ask18:52:22 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
99.680EUR
|
-0.12%
|
- Volumen de negocios: - |
100.450Volumen de oferta: 1,000 |
100.750Tamaño/ Volumen/ Formato de Ask: 1,000 |
20.55 mil millonesEUR |
- |
- |
Descripción de negocio
Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Consejo de gestión & Consejo de supervisión
CEO |
Ivan Tornos |
Consejo de gestión |
Suketu Upadhyay, Mark Bezjak, Rachel Ellingson, Nitin Goyal, David J. Kunz, Angela Main, Keri P. Mattox, Chad Phipps, Paul Stellato, Zeeshan Tariq, Kenneth R. Tripp, Lori Winkler, Sang Yi, Wilfred van Zuilen |
Consejo de supervisión |
Christopher B. Begley, Betsy J. Bernard, Michael J. Farrell, Robert A. Hagemann, Ivan Tornos, Arthur J. Higgins, Maria Teresa Hilado, Syed Jafry, Sreelakshmi Kolli, Michael W. Michelson |
Datos de la empresa
Nombre: |
Zimmer Biomet Holdings Inc. |
Dirección: |
345 East Main Street,Warsaw, Indiana 46580, USA |
Teléfono: |
+1-574-373-3121 |
Fax: |
- |
E-mail: |
surveys@zimmerbiomet.com
|
Internet: |
www.zimmerbiomet.com/ |
Industria: |
Healthcare |
Sector: |
Medical Products |
Subsector: |
Advanced Medical Devices |
Fin del año financiero: |
31/12 |
Acciones de libre circulación: |
74.90% |
Fecha de OPI: |
03/08/2001 |